Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.

Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV.

Am J Psychiatry. 2003 Nov;160(11):1919-28.

PMID:
14594734
2.
3.

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC.

Arch Gen Psychiatry. 1995 Jan;52(1):53-60.

PMID:
7811162
4.

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.

Piccinelli M, Pini S, Bellantuono C, Wilkinson G.

Br J Psychiatry. 1995 Apr;166(4):424-43.

PMID:
7795913
5.

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Soomro GM, Altman D, Rajagopal S, Oakley-Browne M.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001765. doi: 10.1002/14651858.CD001765.pub3. Review.

PMID:
18253995
6.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
7.

A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Pigott TA, Seay SM.

J Clin Psychiatry. 1999 Feb;60(2):101-6. Review.

PMID:
10084636
8.

On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?

Todorov C, Freeston MH, Borgeat F.

Can J Psychiatry. 2000 Apr;45(3):257-62. Review.

PMID:
10779882
9.

Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):163-5.

PMID:
15499694
10.

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder.

Stein DJ, Spadaccini E, Hollander E.

Int Clin Psychopharmacol. 1995 Mar;10(1):11-8.

PMID:
7622800
11.

SSRIs in the treatment of obsessive-compulsive disorder.

Cartwright C, Hollander E.

Depress Anxiety. 1998;8 Suppl 1:105-13. Review.

PMID:
9809222
12.

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.

Am J Psychiatry. 1997 Sep;154(9):1293-5.

PMID:
9286191
13.

Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder.

Ackerman DL, Greenland S.

J Clin Psychopharmacol. 2002 Jun;22(3):309-17.

PMID:
12006902
14.

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

Williams K, Wheeler DM, Silove N, Hazell P.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD004677. doi: 10.1002/14651858.CD004677.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD004677.

PMID:
20687077
15.

Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.

Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ.

Int Clin Psychopharmacol. 2007 Nov;22(6):313-22. Review.

PMID:
17917549
16.

Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.

Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS.

J Child Adolesc Psychopharmacol. 1998;8(1):61-7.

PMID:
9639080
17.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

18.
19.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
20.

Sertraline and obsessive compulsive disorder: new indication. Limited assessment.

[No authors listed]

Prescrire Int. 2000 Aug;9(48):112-3.

PMID:
11067720

Supplemental Content

Support Center